跳至主要内容
临床试验/CTRI/2015/04/005697
CTRI/2015/04/005697已完成4 期

An Open Label, Single Arm, Observational Study to Evaluate Efficacy, Safety and Tolerability of 4-n-butylresorcinol in Patients with Melasm

Micro Labs Ltd0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Subjects with melasma who are either treatment naive or were not on any treatment for at-least 6 months
  • Subjects aged 18 and above years with melasma
  • Subjects with Epidermal type of melasma
  • Subjects with Fitzpatrick skin types III, IV and V
  • Subjects willing to apply sunscreen during the course of study
  • Subjects willing to return for all clinic visits and complete all study-related procedures

排除标准

  • 未提供

研究者

相似试验